Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices), By Ulcer Type (Ischemic, Neuropathic), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030

Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices), By Ulcer Type (Ischemic, Neuropathic), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030


Diabetic Foot Ulcer Treatment Market Growth & Trends

The global diabetic foot ulcer treatment market size is expected to reach USD 7.76 billion by 2030, registering a CAGR of 6.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Many adjuvant therapies such as nonsurgical debridement agents, dressings and topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to effectively improve and cure DFU. Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme allows the body to heal the wound at a quicker rate. Sedentary lifestyle, poor GDP expenditure on healthcare, unhealthy food habits, and poor reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region. Hence, numerous ill effects of DFU are observed in the Asian region.

The biologics segment held the largest revenue share in 2023 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the Covid-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from Covid-19 infection. The market was said to increase at a steady rate in 2021 as Covid-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with Covid-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

Diabetic Foot Ulcer Treatment Market Report Highlights
  • By treatment, the biologics segment captured the largest revenue share in 2023 owing to its reduced wound healing time and increased platelet formation efficiency
  • Based on ulcer type, the neuro-ischemic ulcers segment held the dominant revenue share in 2023
  • The hospitals end-use segment accounted for the second-largest revenue share in 2023 due to the increased adoption rate of treatment and highly experienced staff
  • North America grabbed the largest revenue share in 2023 due to the presence of market players and improved treatment cost and reimbursement scenario
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology And Scope
1.1 Market Segmentation
1.2 Market Definition
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
Chapter 2 Executive Summary
2.1 Market Snapshot (Regional)
2.2 Segment Snapshot (Treatment And Type)
2.3 Segment Snapshot (End-Use)
2.4 Competitive Landscape
Chapter 3 Diabetic Foot Ulcer Treatment Market Variables And Trends
3.1 Market Lineage Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Growing Prevalence Of Diabetes
3.2.1.2 Rising Geriatric Population
3.2.1.3 Increasing Government Initiative
3.2.2 Market Restraint Impact Analysis
3.2.2.1 High Cost Of Treatment
3.3 Industry Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Macroeconomic Analysis
3.4 Covid-19 Impact Analysis
3.4.1 Post-Pandemic Market Insights
3.5 Supply Chain Analysis
Chapter 4 Diabetic Foot Ulcer Treatment Market: Treatment Analysis
4.1 Treatment Movement Analysis & Market Share, 2022 & 2030
4.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Treatment (USD Million)
4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
4.3.1 Wound Care Dressings
4.3.1.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
4.3.1.2 Alginate Dressings
4.3.1.2.1 Alginate Dressings Market, 2018 - 2030 (USD Million)
4.3.1.3 Hydrofiber Dressings
4.3.1.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
4.3.1.4 Foam Dressings
4.3.1.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
4.3.1.5 Film Dressing
4.3.1.5.1 Film Dressing Market, 2018 - 2030 (USD Million)
4.3.1.6 Hydrocolloid Dressings
4.3.1.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
4.3.1.7 Surgical Dressings
4.3.1.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
4.3.1.8 Hydrogel Dressings
4.3.1.8.1 Hydrogel Dressings Market, 2018 - 2030 (USD Million)
4.3.2 Biologics
4.3.2.1 Biologics Market, 2018 - 2030 (USD Million)
4.3.2.2 Growth Factors
4.3.2.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
4.3.2.3 Skin Grafts
4.3.2.3.1 Skin Grafts Market, 2018 - 2030 (USD Million)
4.3.3 Therapy Devices
4.3.3.1 Therapy Devices Market, 2018 - 2030 (USD Million)
4.3.3.2 Negative Pressure Wound Therapy
4.3.3.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
4.3.3.3 Ultrasound Therapy
4.3.3.3.1 Ultrasound Therapy Market, 2018 - 2030 (USD Million)
4.3.4 Antibiotic Medications
4.3.4.1 Antibiotic Medications Market, 2018 - 2030 (USD Million)
4.3.5 Others
4.3.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Diabetic Foot Ulcer Treatment Market: Type Analysis
5.1 Type Movement Analysis & Market Share, 2022 & 2030
5.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Type (USD Million)
5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
5.3.1 Neuropathic Ulcers
5.3.1.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
5.3.2 Ischemic Ulcers
5.3.2.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
5.3.3 Neuro-Ischemic Ulcers
5.3.3.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)
Chapter 6 Diabetic Foot Ulcer Treatment Market: End-Use Analysis
6.1 End-Use Movement Analysis & Market Share, 2022 & 2030
6.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By End-Use (USD Million)
6.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
6.3.1 Hospitals
6.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
6.3.2 Ambulatory Surgical Centers
6.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
6.3.3 Homecare
6.3.3.1 Homecare Market, 2018 - 2030 (USD Million)
Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis
7.1 Diabetic Foot Ulcer Treatment Market: Regional Outlook
7.2 North America
7.2.1 North America Diabetic Foot Ulcer Treatment Market Estimates & Forecasts, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.2.5 U.S. Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Competitive Scenario
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.2.3.5 Canada Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2 U.K
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.2.5 U.K Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.3.5 Germany Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.4.5 France Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.5.5 Italy Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.6.5 Spain Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7 Sweden
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.7.5 Sweden Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.8 Denmark
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.8.5 Denmark Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Key Country Dynamics
7.3.9.2 Competitive Scenario
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.3.9.5 Norway Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.2.5 Japan Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.3.5 China Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.4.5 India Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.5.5 Australia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.6.5 South Korea Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Key Country Dynamics
7.4.7.2 Competitive Scenario
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.4.7.5 Thailand Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.2.5 Brazil Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Framework
7.5.3.4 Reimbursement Scenario
7.5.3.5 Mexico Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Key Country Dynamics
7.5.4.2 Competitive Scenario
7.5.4.3 Regulatory Framework
7.5.4.4 Reimbursement Scenario
7.5.4.5 Argentina Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 Competitive Scenario
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.2.5 South Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Competitive Scenario
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.3.5 Saudi Arabia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 Key Country Dynamics
7.6.4.2 Competitive Scenario
7.6.4.3 Regulatory Framework
7.6.4.4 Reimbursement Scenario
7.6.4.5 UAE Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Key Country Dynamics
7.6.5.2 Competitive Scenario
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario
7.6.5.5 Kuwait Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Analysis
8.1 Company Categorization
8.2 Participants’ Overview
8.3 Financial Performance
8.4 Product Benchmarking
8.5 Company Market Share Analysis, 2023
8.6 Company Market Position Analysis
8.7 Strategy Mapping
8.7.1 Mergers & Acquisitions
8.7.2 New Product Launch
8.7.3 Partnerships & Collaborations
8.7.4 Expansion
8.7.5 Others
8.8 Company Profiles
8.8.1 ConvaTec, Group Plc
8.8.1.1 Company overview
8.8.1.2 Finacial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 Acelity L.P., Inc.
8.8.2.1 Company overview
8.8.2.2 Finacial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 3M Health Care
8.8.3.1 Company overview
8.8.3.2 Finacial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 Coloplast Corp.
8.8.4.1 Company overview
8.8.4.2 Finacial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 Smith & Nephew Plc
8.8.5.1 Company overview
8.8.5.2 Finacial performance
8.8.5.3 Product benchmarking
8.8.5.4 Strategic initiatives
8.8.6 B. Braun Melsungen AG
8.8.6.1 Company overview
8.8.6.2 Finacial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 Medline Industries, LP.
8.8.7.1 Company overview
8.8.7.2 Finacial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 Molnlycke Health Care AB
8.8.8.1 Company overview
8.8.8.2 Finacial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives
8.8.9 Medtronic Plc
8.8.9.1 Company overview
8.8.9.2 Finacial performance
8.8.9.3 Product benchmarking
8.8.9.4 Strategic initiatives
Chapter 9 Analyst Perspective

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings